2-Hydroxypropyl-beta-cyclodextrin
"2-Hydroxypropyl-beta-cyclodextrin" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Derivative of beta-cyclodextrin that is used as an excipient for steroid drugs and as a lipid chelator.
Descriptor ID |
D000073738
|
MeSH Number(s) |
D04.345.103.333.500 D09.301.915.400.375.333.500 D09.698.365.855.400.375.333.500
|
Concept/Terms |
2-Hydroxypropyl-beta-cyclodextrin- 2-Hydroxypropyl-beta-cyclodextrin
- 2 Hydroxypropyl beta cyclodextrin
- beta-Hydroxypropylcyclodextrin
- beta Hydroxypropylcyclodextrin
- HPbetaCD
- Hydroxypropyl Betadex
- Betadex, Hydroxypropyl
- HP-beta-CD
- 2 Hydroxypropyl-beta-cyclodextrin
- Hydroxypropyl-beta-cyclodextrin
- Hydroxypropyl beta cyclodextrin
|
Below are MeSH descriptors whose meaning is more general than "2-Hydroxypropyl-beta-cyclodextrin".
Below are MeSH descriptors whose meaning is more specific than "2-Hydroxypropyl-beta-cyclodextrin".
This graph shows the total number of publications written about "2-Hydroxypropyl-beta-cyclodextrin" by people in this website by year, and whether "2-Hydroxypropyl-beta-cyclodextrin" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
Year | Major Topic | Minor Topic | Total |
---|
2001 | 0 | 1 | 1 | 2004 | 0 | 2 | 2 | 2008 | 0 | 1 | 1 | 2010 | 0 | 1 | 1 | 2011 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "2-Hydroxypropyl-beta-cyclodextrin" by people in Profiles.
-
Zoeller MP, Hafiz S, Marx A, Erwin N, Fricker G, Carpenter JF. Exploring the Protein Stabilizing Capability of Surfactants Against Agitation Stress and the Underlying Mechanisms. J Pharm Sci. 2022 12; 111(12):3261-3274.
-
Christensen K, Daniels S, Bandy D, Ernst CC, Hamilton DA, Mermelstein FH, Wang J, Carr DB. A double-blind placebo-controlled comparison of a novel formulation of intravenous diclofenac and ketorolac for postoperative third molar extraction pain. Anesth Prog. 2011; 58(2):73-81.
-
Serno T, Carpenter JF, Randolph TW, Winter G. Inhibition of agitation-induced aggregation of an IgG-antibody by hydroxypropyl-beta-cyclodextrin. J Pharm Sci. 2010 Mar; 99(3):1193-206.
-
Abrams DJ, Zheng L, Choo KS, Yang JJ, Wei W, Anchordoquy TJ, Zawia NH, Stevens KE. An initial animal proof-of-concept study for central administration of clozapine to schizophrenia patients. Schizophr Res. 2008 Mar; 100(1-3):86-96.
-
Buchanan CM, Buchanan NL, Edgar KJ, Klein S, Little JL, Ramsey MG, Ruble KM, Wacher VJ, Wempe MF. Pharmacokinetics of itraconazole after intravenous and oral dosing of itraconazole-cyclodextrin formulations. J Pharm Sci. 2007 Nov; 96(11):3100-16.
-
Bandi N, Wei W, Roberts CB, Kotra LP, Kompella UB. Preparation of budesonide- and indomethacin-hydroxypropyl-beta-cyclodextrin (HPBCD) complexes using a single-step, organic-solvent-free supercritical fluid process. Eur J Pharm Sci. 2004 Oct; 23(2):159-68.
-
Koushik K, Dhanda DS, Cheruvu NP, Kompella UB. Pulmonary delivery of deslorelin: large-porous PLGA particles and HPbetaCD complexes. Pharm Res. 2004 Jul; 21(7):1119-26.
-
Koushik KN, Bandi N, Kompella UB. Interaction of [D-Trp6, Des-Gly10] LHRH ethylamide and hydroxy propyl beta-cyclodextrin (HPbetaCD): thermodynamics of interaction and protection from degradation by alpha-chymotrypsin. Pharm Dev Technol. 2001 Nov; 6(4):595-606.
|
People People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|